News for 'generic information'

Dear women, want advice on personal finance? Send in your questions!

Dear women, want advice on personal finance? Send in your questions!

Rediff.com19 Aug 2019

Hena Mehta will answer Your Questions on personal finance on a weekly basis. Please mail your questions to getahead@rediff.co.in with the subject line 'Personal Finance Query' along with your name and Hena will offer his helpful advice.

Drug patent settlements to come under EU scanner

Drug patent settlements to come under EU scanner

Rediff.com13 Jan 2010

In a statement on Tuesday, the European Commission said it had requested 'information from certain pharma companies asking them to submit copies of their patent settlement pacts.'

10 stocks that FPIs bought and sold the most

10 stocks that FPIs bought and sold the most

Rediff.com12 May 2022

The FPI holding in India's top 100 companies, which are part of the Nifty 100 index, declined to 24.23 per cent on average at the end of March this year, from a high of 27.5 per cent at the end of March 2021. This is the lowest FPI holdings in India's top listed companies in at least three years. A general sell-off by FPIs has weighed on stock prices and the benchmark S&P BSE Sensex is down 8.5 per cent, from its 52-week high made in October 2021. Most analysts expect FPI flows to remain weak in FY23 as well, given rising bond yields in the US and an expected earnings slowdown in India due to high inflation and commodity prices.

Shopian: Army files counter-FIR; says fired after 'ultimate provocation'

Shopian: Army files counter-FIR; says fired after 'ultimate provocation'

Rediff.com31 Jan 2018

Calling the FIR against the army as 'unfortunate', Lt Gen Anbu said that there should have been generic FIR in the matter.

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

Rediff.com24 Jun 2013

FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.

'Ranbaxy got USFDA nod with no data or fraudulent data'

'Ranbaxy got USFDA nod with no data or fraudulent data'

Rediff.com7 Nov 2013

In May this year, Ranbaxy had pleaded guilty to 'felony charges' for violating manufacturing norms and agreed to pay $500 million penalty to US authorities.

What Vikas Yatra is Modi talking about?

What Vikas Yatra is Modi talking about?

Rediff.com14 Jun 2021

A report by the Azim Premji University showed that during the pandemic 270 million Indians were pushed into poverty. Meaning that they were not poor according to the government poverty line before, but have become now. Aakar Patel mulls on the state of the nation as the Modi government enters its eighth year.

10 reasons why your CV was REJECTED!

10 reasons why your CV was REJECTED!

Rediff.com9 Oct 2019

Unless you are a fresher, you should not circulate a generic CV for all openings, says Achin Bhattacharyya.

Why Japan is betting big on Indian pharma cos

Why Japan is betting big on Indian pharma cos

Rediff.com26 Jan 2017

One reason Japan is betting highly on Indian pharma is that these companies have strong cash flows, low leverage and high debt capacity for medium to large sized acquisitions.

Must see: How to get an internship at Deloitte India

Must see: How to get an internship at Deloitte India

Rediff.com25 Jul 2019

Deloitte's recruitment process will involve a resume screening, a telephonic interview, and a face-to-face interview if you apply online, says Sarvesh Agrawal.

US big 3 look for new Indian drug suppliers

US big 3 look for new Indian drug suppliers

Rediff.com17 Nov 2007

Generic drug sales in the US, that power the business of such leading Indian drug manufacturers as Ranbaxy, Dr Reddy's, Sun Pharma, Lupin and Zydus Cadila, will face competition soon, as big US wholesalers decide to outsource their requirements from upcoming Indian manufacturers.

New to online dating? 10 tips to be safe than sorry

New to online dating? 10 tips to be safe than sorry

Rediff.com7 Sep 2020

On the initial dates, avoid going somewhere private with your date, advises Ravi Mittal, founder, Quack Quack, an online dating app.

Strides, STADA plan drug for US

Strides, STADA plan drug for US

Rediff.com14 Apr 2005

Strides Arcolab Ltd's, US subsidiary Strides Inc and STADA Pharmaceuticals Inc, the US subsidiary of STADA Arzneimittel AG, have signed a development and supply agreement for a prescription generic drug product for the US market.

Unichem inks pact with US co

Unichem inks pact with US co

Rediff.com19 May 2006

Pharmaceutical company Unichem Laboratories Ltd said on Friday it has entered into a product development, manufacturing and supply agreement with US-based PLIVA Inc.

Stocks: Bulls ran wild in COVID-19

Stocks: Bulls ran wild in COVID-19

Rediff.com11 Jan 2021

Indian equities are no longer cheap vis-a-vis global markets, and only a short distance away from being the most expensive they have ever been.

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Rediff.com21 Oct 2014

On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.

Wockhardt get US nod for anti-epileptic drug

Wockhardt get US nod for anti-epileptic drug

Rediff.com14 Jun 2006

Wockhardt Ltd has received tentative approval from the USFDA for anti-epileptic drug, Divalproex Sodium delayed-release tablets.

Scared of filing income tax return? Here's help

Scared of filing income tax return? Here's help

Rediff.com2 Mar 2016

You don't need to be intimidated by the thought of filing tax returns

Ranbaxy buys out 18 drugs from Spanish co

Ranbaxy buys out 18 drugs from Spanish co

Rediff.com9 Jun 2005

Ranbaxy Laboratories has acquired a generic product portfolio accounting for eighteen products belonging to the Spanish pharmaceutical Company Efarmes, S. A. Unipersonal for sale in the Spanish market.

Ranbaxy gets USFDA nod for new drug

Ranbaxy gets USFDA nod for new drug

Rediff.com1 Apr 2005

Ranbaxy Laboratories on Friday said it had received approval from US Food and Drug Administration to manufacture and market nitrofurantoin monohydrate macrocrystals capsules (100 mg) and planned to bring the new drug to the market in April.

Sanjay Valvani, New York hedge fund exec found dead in apparent suicide

Sanjay Valvani, New York hedge fund exec found dead in apparent suicide

Rediff.com22 Jun 2016

Prosecutors unveiled charges against Valvani alleging he fraudulently made $25 million by getting advance information about US Food and Drug Administration approvals of generic drug applications

Alpharma to sell Orchid drugs in US

Alpharma to sell Orchid drugs in US

Rediff.com24 Feb 2005

Orchid Chemicals and Pharmaceuticals Ltd has entered into an exclusive agreement with Alpharma Inc for marketing its select non-antibiotic generic formulations in the US and Europe.

Dr Reddy's gets USFDA nod for glimepiride

Dr Reddy's gets USFDA nod for glimepiride

Rediff.com10 Oct 2005

Hyderabad based Dr Reddy's Laboratories has received approval from the US Food and Drugs Administration for multiple strengths of anti-diabetes drug glimepiride tablets.

Ranbaxy gets nod for Fluoxetine

Ranbaxy gets nod for Fluoxetine

Rediff.com15 Dec 2004

United States' Food and Drug Administration has granted approval to Ranbaxy Laboratories Ltd to manufacture and market 40 mg capsules of Fluoxetine, a drug used in treatment of obsessive-compulsive disorders.\n\n

10 large caps for good returns in 2021

10 large caps for good returns in 2021

Rediff.com15 Jan 2021

Investment in market leaders with a safety-first approach could yield reasonable returns across sectors.

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Rediff.com27 Feb 2014

Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.

Aurobindo gets FDA nod for drug

Aurobindo gets FDA nod for drug

Rediff.com27 Sep 2005

Aurobindo Pharma Ltd on Tuesday said it has received tentative approval from the US FDA for its Sertraline

Sun-Ranbaxy deal signals Indian pharma cos are smart targets

Sun-Ranbaxy deal signals Indian pharma cos are smart targets

Rediff.com8 Apr 2014

The Ranbaxy experience has made multinational corporations more cautious about Indian acquisitions in general

Internet is creating the digital divide, says Amartya Sen

Internet is creating the digital divide, says Amartya Sen

Rediff.com7 Jan 2016

Free Basics offers a limited version of the Internet on mobile phones.

A pharmacy store in your pocket!

A pharmacy store in your pocket!

Rediff.com16 May 2016

1mg has made buying medicines easy and it aims to do more in online health care.

Shanghai Fosun to buy Gland Pharma for $1.4 billion

Shanghai Fosun to buy Gland Pharma for $1.4 billion

Rediff.com27 Jul 2016

The founders of Gland Pharma, led by Ravi Penmetsa, and KKR, together own 96 per cent of the company.

India's FDI during Apr-Feb jumps to $37.53 billion

India's FDI during Apr-Feb jumps to $37.53 billion

Rediff.com2 May 2016

Services attracted the most FDI during the first eleven months period of 2015-16.

Want a high paying job? Here's what you should specialise in

Want a high paying job? Here's what you should specialise in

Rediff.com20 Feb 2019

Global companies, e-commerce platforms and software product firms all want skilled digital workers.

MFs to Create LONG-TERM Wealth

MFs to Create LONG-TERM Wealth

Rediff.com9 Aug 2021

Omkeshwar Singh, Head, Rank MF, a mutual fund investment platform, answers your queries.

Govt issues guidelines for reopening of gyms, yoga centres

Govt issues guidelines for reopening of gyms, yoga centres

Rediff.com3 Aug 2020

The guidelines lay down the processes and premises redesigning, including proper placement of equipments. Yoga institutes and gymnasiums have been asked to plan the floor area based on four metres squared per person.

India blundered along, exactly as every other country did

India blundered along, exactly as every other country did

Rediff.com23 Jun 2021

Not to say that India couldn't have handled the situation better, but on average, it didn't do anywhere near as badly as the naysayers make it out argues Rajeev Srinivasan.

People's medicine scheme is a non-performer

People's medicine scheme is a non-performer

Rediff.com17 May 2017

The Pradhan Mantri Jan Aushadhi Yojana or PMJAY has not been a runaway success by any yardstick. Not all stores are running, and many are poorly stocked.

'Vaccinations are not a 100% guarantee'

'Vaccinations are not a 100% guarantee'

Rediff.com14 Jul 2021

'The reality of this virus is that as long as it is circulating, it can mutate into new variants and by the time you realise that this is a new virus, which is more dangerous, and more transmissible, it is too late.'

USFDA issues import alert on Ranbaxy's Mohali plant

USFDA issues import alert on Ranbaxy's Mohali plant

Rediff.com16 Sep 2013

While the US health regulator did not specify details for issuing the alert, it said 'detention without physical examination may be appropriate when an FDA inspection has revealed that a firm is not operating in conformity with current good manufacturing practices'.

How India shopped online this festive season

How India shopped online this festive season

Rediff.com8 Nov 2018

What sold the most this year? Beauty, toys and baby care, sports and fitness, television and large appliances, followed by fashion, says T E Narasimhan.